T-cell sensitisation to hepatitis B virus surface antigens

Area of Science:

• Immunology
• Virology
• Cellular Biology

Background:

• Hepatitis B virus (HBV) infection affects millions globally.
• Cellular immunity, particularly T-cell responses, plays a crucial role in HBV infection clearance.
• Understanding immune responses to hepatitis B surface antigens (HBsAg) is key to vaccine development and treatment strategies.

Purpose of the Study:

• To investigate cellular immunity to HBsAg subtypes (ad and ay) in adult individuals with different HBV infection statuses.
• To compare interferon-gamma (IFN-gamma) production by peripheral blood mononuclear cells (PBMCs) in response to HBsAg stimulation across patient groups.

Main Methods:

• Peripheral blood mononuclear cells (PBMCs) were isolated from individuals with acute HBV, chronic HBV, recovered HBV, and healthy vaccinated controls.
• PBMCs were stimulated in vitro with HBsAg ad and HBsAg ay subtypes.
• Interferon-gamma (IFN-gamma) levels in PBMC culture supernatants were quantified using ELISA.

Main Results:

• PBMCs from acute and chronic HBV patients showed minimal IFN-gamma response to both HBsAg subtypes.
• Recovered HBV patients exhibited a significant IFN-gamma response to both HBsAg ad and ay subtypes.
• Uninfected vaccinated controls showed a moderate IFN-gamma response to HBsAg stimulation.

Conclusions:

• Cellular immunity to HBsAg is suppressed during acute and chronic HBV infections.
• Restored cellular immunity, indicated by strong IFN-gamma production, is associated with recovery from HBV infection.
• These findings highlight the importance of cellular immune responses in HBV clearance and suggest potential targets for therapeutic interventions.